The global market for Piriformis Syndrome was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.

The North American region is anticipated to dominate the market due to the existing well-established healthcare system, increasing healthcare expenditure, growing awareness about the syndrome, and rising geriatric population.

This report aims to provide a comprehensive presentation of the global market for Piriformis Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piriformis Syndrome.

The Piriformis Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Piriformis Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Piriformis Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Piriformis Syndrome Market Report

Report Metric	Details
Report Name	Piriformis Syndrome Market
Segment by Type	Medication Physical Therapy Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Sanofi, Bayer, AstraZeneca, Teva Pharmaceuticals, Endo Pharmaceuticals, Omron Healthcare, DePuy Synthes, Miracle Stretch, Seirin Corporation, Nidd Valley Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Piriformis Syndrome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Piriformis Syndrome Market report?

Ans: The main players in the Piriformis Syndrome Market are Novartis, Sanofi, Bayer, AstraZeneca, Teva Pharmaceuticals, Endo Pharmaceuticals, Omron Healthcare, DePuy Synthes, Miracle Stretch, Seirin Corporation, Nidd Valley Medical

What are the Application segmentation covered in the Piriformis Syndrome Market report?

Ans: The Applications covered in the Piriformis Syndrome Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Piriformis Syndrome Market report?

Ans: The Types covered in the Piriformis Syndrome Market report are Medication, Physical Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Piriformis Syndrome Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Medication

1.2.3 Physical Therapy

1.2.4 Others

1.3 Market by Application

1.3.1 Global Piriformis Syndrome Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Piriformis Syndrome Market Perspective (2020-2031)

2.2 Global Piriformis Syndrome Growth Trends by Region

2.2.1 Global Piriformis Syndrome Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Piriformis Syndrome Historic Market Size by Region (2020-2025)

2.2.3 Piriformis Syndrome Forecasted Market Size by Region (2026-2031)

2.3 Piriformis Syndrome Market Dynamics

2.3.1 Piriformis Syndrome Industry Trends

2.3.2 Piriformis Syndrome Market Drivers

2.3.3 Piriformis Syndrome Market Challenges

2.3.4 Piriformis Syndrome Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Piriformis Syndrome Players by Revenue

3.1.1 Global Top Piriformis Syndrome Players by Revenue (2020-2025)

3.1.2 Global Piriformis Syndrome Revenue Market Share by Players (2020-2025)

3.2 Global Piriformis Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Piriformis Syndrome Revenue

3.4 Global Piriformis Syndrome Market Concentration Ratio

3.4.1 Global Piriformis Syndrome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Piriformis Syndrome Revenue in 2024

3.5 Global Key Players of Piriformis Syndrome Head office and Area Served

3.6 Global Key Players of Piriformis Syndrome, Product and Application

3.7 Global Key Players of Piriformis Syndrome, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Piriformis Syndrome Breakdown Data by Type

4.1 Global Piriformis Syndrome Historic Market Size by Type (2020-2025)

4.2 Global Piriformis Syndrome Forecasted Market Size by Type (2026-2031)

5 Piriformis Syndrome Breakdown Data by Application

5.1 Global Piriformis Syndrome Historic Market Size by Application (2020-2025)

5.2 Global Piriformis Syndrome Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Piriformis Syndrome Market Size (2020-2031)

6.2 North America Piriformis Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Piriformis Syndrome Market Size by Country (2020-2025)

6.4 North America Piriformis Syndrome Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Piriformis Syndrome Market Size (2020-2031)

7.2 Europe Piriformis Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Piriformis Syndrome Market Size by Country (2020-2025)

7.4 Europe Piriformis Syndrome Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Piriformis Syndrome Market Size (2020-2031)

8.2 Asia-Pacific Piriformis Syndrome Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Piriformis Syndrome Market Size by Region (2020-2025)

8.4 Asia-Pacific Piriformis Syndrome Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Piriformis Syndrome Market Size (2020-2031)

9.2 Latin America Piriformis Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Piriformis Syndrome Market Size by Country (2020-2025)

9.4 Latin America Piriformis Syndrome Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Piriformis Syndrome Market Size (2020-2031)

10.2 Middle East & Africa Piriformis Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Piriformis Syndrome Market Size by Country (2020-2025)

10.4 Middle East & Africa Piriformis Syndrome Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Piriformis Syndrome Introduction

11.1.4 Novartis Revenue in Piriformis Syndrome Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Piriformis Syndrome Introduction

11.2.4 Sanofi Revenue in Piriformis Syndrome Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Piriformis Syndrome Introduction

11.3.4 Bayer Revenue in Piriformis Syndrome Business (2020-2025)

11.3.5 Bayer Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Piriformis Syndrome Introduction

11.4.4 AstraZeneca Revenue in Piriformis Syndrome Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Details

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Piriformis Syndrome Introduction

11.5.4 Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2020-2025)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 Endo Pharmaceuticals

11.6.1 Endo Pharmaceuticals Company Details

11.6.2 Endo Pharmaceuticals Business Overview

11.6.3 Endo Pharmaceuticals Piriformis Syndrome Introduction

11.6.4 Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2020-2025)

11.6.5 Endo Pharmaceuticals Recent Development

11.7 Omron Healthcare

11.7.1 Omron Healthcare Company Details

11.7.2 Omron Healthcare Business Overview

11.7.3 Omron Healthcare Piriformis Syndrome Introduction

11.7.4 Omron Healthcare Revenue in Piriformis Syndrome Business (2020-2025)

11.7.5 Omron Healthcare Recent Development

11.8 DePuy Synthes

11.8.1 DePuy Synthes Company Details

11.8.2 DePuy Synthes Business Overview

11.8.3 DePuy Synthes Piriformis Syndrome Introduction

11.8.4 DePuy Synthes Revenue in Piriformis Syndrome Business (2020-2025)

11.8.5 DePuy Synthes Recent Development

11.9 Miracle Stretch

11.9.1 Miracle Stretch Company Details

11.9.2 Miracle Stretch Business Overview

11.9.3 Miracle Stretch Piriformis Syndrome Introduction

11.9.4 Miracle Stretch Revenue in Piriformis Syndrome Business (2020-2025)

11.9.5 Miracle Stretch Recent Development

11.10 Seirin Corporation

11.10.1 Seirin Corporation Company Details

11.10.2 Seirin Corporation Business Overview

11.10.3 Seirin Corporation Piriformis Syndrome Introduction

11.10.4 Seirin Corporation Revenue in Piriformis Syndrome Business (2020-2025)

11.10.5 Seirin Corporation Recent Development

11.11 Nidd Valley Medical

11.11.1 Nidd Valley Medical Company Details

11.11.2 Nidd Valley Medical Business Overview

11.11.3 Nidd Valley Medical Piriformis Syndrome Introduction

11.11.4 Nidd Valley Medical Revenue in Piriformis Syndrome Business (2020-2025)

11.11.5 Nidd Valley Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Piriformis Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Medication

Table 3. Key Players of Physical Therapy

Table 4. Key Players of Others

Table 5. Global Piriformis Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Piriformis Syndrome Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Piriformis Syndrome Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Piriformis Syndrome Market Share by Region (2020-2025)

Table 9. Global Piriformis Syndrome Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Piriformis Syndrome Market Share by Region (2026-2031)

Table 11. Piriformis Syndrome Market Trends

Table 12. Piriformis Syndrome Market Drivers

Table 13. Piriformis Syndrome Market Challenges

Table 14. Piriformis Syndrome Market Restraints

Table 15. Global Piriformis Syndrome Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Piriformis Syndrome Market Share by Players (2020-2025)

Table 17. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piriformis Syndrome as of 2024)

Table 18. Ranking of Global Top Piriformis Syndrome Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Piriformis Syndrome Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Piriformis Syndrome, Headquarters and Area Served

Table 21. Global Key Players of Piriformis Syndrome, Product and Application

Table 22. Global Key Players of Piriformis Syndrome, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Piriformis Syndrome Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Piriformis Syndrome Revenue Market Share by Type (2020-2025)

Table 26. Global Piriformis Syndrome Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Piriformis Syndrome Revenue Market Share by Type (2026-2031)

Table 28. Global Piriformis Syndrome Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Piriformis Syndrome Revenue Market Share by Application (2020-2025)

Table 30. Global Piriformis Syndrome Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Piriformis Syndrome Revenue Market Share by Application (2026-2031)

Table 32. North America Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Piriformis Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Piriformis Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Piriformis Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Piriformis Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Piriformis Syndrome Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Piriformis Syndrome Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Piriformis Syndrome Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Piriformis Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Piriformis Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Piriformis Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Piriformis Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis Piriformis Syndrome Product

Table 50. Novartis Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Sanofi Company Details

Table 53. Sanofi Business Overview

Table 54. Sanofi Piriformis Syndrome Product

Table 55. Sanofi Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 56. Sanofi Recent Development

Table 57. Bayer Company Details

Table 58. Bayer Business Overview

Table 59. Bayer Piriformis Syndrome Product

Table 60. Bayer Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 61. Bayer Recent Development

Table 62. AstraZeneca Company Details

Table 63. AstraZeneca Business Overview

Table 64. AstraZeneca Piriformis Syndrome Product

Table 65. AstraZeneca Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 66. AstraZeneca Recent Development

Table 67. Teva Pharmaceuticals Company Details

Table 68. Teva Pharmaceuticals Business Overview

Table 69. Teva Pharmaceuticals Piriformis Syndrome Product

Table 70. Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 71. Teva Pharmaceuticals Recent Development

Table 72. Endo Pharmaceuticals Company Details

Table 73. Endo Pharmaceuticals Business Overview

Table 74. Endo Pharmaceuticals Piriformis Syndrome Product

Table 75. Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 76. Endo Pharmaceuticals Recent Development

Table 77. Omron Healthcare Company Details

Table 78. Omron Healthcare Business Overview

Table 79. Omron Healthcare Piriformis Syndrome Product

Table 80. Omron Healthcare Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 81. Omron Healthcare Recent Development

Table 82. DePuy Synthes Company Details

Table 83. DePuy Synthes Business Overview

Table 84. DePuy Synthes Piriformis Syndrome Product

Table 85. DePuy Synthes Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 86. DePuy Synthes Recent Development

Table 87. Miracle Stretch Company Details

Table 88. Miracle Stretch Business Overview

Table 89. Miracle Stretch Piriformis Syndrome Product

Table 90. Miracle Stretch Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 91. Miracle Stretch Recent Development

Table 92. Seirin Corporation Company Details

Table 93. Seirin Corporation Business Overview

Table 94. Seirin Corporation Piriformis Syndrome Product

Table 95. Seirin Corporation Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 96. Seirin Corporation Recent Development

Table 97. Nidd Valley Medical Company Details

Table 98. Nidd Valley Medical Business Overview

Table 99. Nidd Valley Medical Piriformis Syndrome Product

Table 100. Nidd Valley Medical Revenue in Piriformis Syndrome Business (2020-2025) & (US$ Million)

Table 101. Nidd Valley Medical Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Piriformis Syndrome Picture

Figure 2. Global Piriformis Syndrome Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Piriformis Syndrome Market Share by Type: 2024 VS 2031

Figure 4. Medication Features

Figure 5. Physical Therapy Features

Figure 6. Others Features

Figure 7. Global Piriformis Syndrome Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Piriformis Syndrome Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Piriformis Syndrome Report Years Considered

Figure 13. Global Piriformis Syndrome Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Piriformis Syndrome Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Piriformis Syndrome Market Share by Region: 2024 VS 2031

Figure 16. Global Piriformis Syndrome Market Share by Players in 2024

Figure 17. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piriformis Syndrome as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Piriformis Syndrome Revenue in 2024

Figure 19. North America Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Piriformis Syndrome Market Share by Country (2020-2031)

Figure 21. United States Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Piriformis Syndrome Market Share by Country (2020-2031)

Figure 25. Germany Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Piriformis Syndrome Market Share by Region (2020-2031)

Figure 33. China Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Piriformis Syndrome Market Share by Country (2020-2031)

Figure 41. Mexico Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Piriformis Syndrome Market Share by Country (2020-2031)

Figure 45. Turkey Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Piriformis Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 51. AstraZeneca Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 53. Endo Pharmaceuticals Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 54. Omron Healthcare Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 55. DePuy Synthes Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 56. Miracle Stretch Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 57. Seirin Corporation Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 58. Nidd Valley Medical Revenue Growth Rate in Piriformis Syndrome Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-6F17019

Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Global Neuromodulation and Neurostimulation Pain Management Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-0L17453

Thu Nov 06 00:00:00 UTC 2025

Add to Cart

Global Pain Relief Gel Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-35S16884

Thu Nov 06 00:00:00 UTC 2025

Add to Cart

Global Locoplex Plexus and Peripheral Nerve Block Needle Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-25Q17042

Tue Nov 04 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Piriformis Syndrome Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-34U1604

Global Piriformis Syndrome Market Research Report 2025

FEATURED COMPANIES

Piriformis Syndrome Market

Scope of Piriformis Syndrome Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Piriformis Syndrome Market report?

What are the Application segmentation covered in the Piriformis Syndrome Market report?

What are the Type segmentation covered in the Piriformis Syndrome Market report?

FEATURED COMPANIES

RELATED REPORTS